CSBR
CHAMPIONS ONCOLOGY, INC.
NASDAQ · Healthcare · Biotechnology · US
$5.15
+1.28%Sep 10, 2026, 20:00 UTC
Champions Oncology reported first-quarter fiscal 2027 revenue of $15.2 million, up 8.8% year over year, with oncology services margin of 51% and adjusted EBITDA of $671,000.
Jul 27, 2026, 20:00 UTC
Champions Oncology reported record annual revenue of $59.4 million for fiscal year 2026, with fourth quarter revenue of $13.8 million and positive adjusted EBITDA for the fourth consecutive quarter.